Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2012 | 2 |
2013 | 1 |
2016 | 2 |
2023 | 0 |
Search Results
5 results
Results by year
Page 1
Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by anti-tumor triazoloacridinone C-1305.
Xenobiotica. 2016 Dec;46(12):1056-1065. doi: 10.3109/00498254.2016.1147623. Epub 2016 Feb 29.
Xenobiotica. 2016.
PMID: 26928326
Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes.
Potęga A, Fedejko-Kap B, Mazerska Z.
Potęga A, et al. Among authors: fedejko kap b.
Pharmacol Rep. 2016 Aug;68(4):663-70. doi: 10.1016/j.pharep.2016.02.003. Epub 2016 Mar 16.
Pharmacol Rep. 2016.
PMID: 27110874
Item in Clipboard
Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.
Pawlowska M, Chu R, Fedejko-Kap B, Augustin E, Mazerska Z, Radominska-Pandya A, Chambers TC.
Pawlowska M, et al. Among authors: fedejko kap b.
Drug Metab Dispos. 2013 Feb;41(2):414-21. doi: 10.1124/dmd.112.047811. Epub 2012 Nov 16.
Drug Metab Dispos. 2013.
PMID: 23160818
Free PMC article.
Item in Clipboard
Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.
Fedejko-Kap B, Niemira M, Radominska-Pandya A, Mazerska Z.
Fedejko-Kap B, et al.
Xenobiotica. 2011 Dec;41(12):1044-55. doi: 10.3109/00498254.2011.604743. Epub 2011 Aug 23.
Xenobiotica. 2011.
PMID: 21859392
Item in Clipboard
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.
Fedejko-Kap B, Bratton SM, Finel M, Radominska-Pandya A, Mazerska Z.
Fedejko-Kap B, et al.
Drug Metab Dispos. 2012 Sep;40(9):1736-43. doi: 10.1124/dmd.112.045401. Epub 2012 Jun 1.
Drug Metab Dispos. 2012.
PMID: 22659092
Free PMC article.
Item in Clipboard
Cite
Cite